102.69
Schlusskurs vom Vortag:
$108.25
Offen:
$104
24-Stunden-Volumen:
3.72M
Relative Volume:
2.45
Marktkapitalisierung:
$20.44B
Einnahmen:
$7.60B
Nettoeinkommen (Verlust:
$1.08B
KGV:
19.52
EPS:
5.26
Netto-Cashflow:
$1.26B
1W Leistung:
-7.17%
1M Leistung:
-0.84%
6M Leistung:
-6.28%
1J Leistung:
-19.52%
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ZBH
Zimmer Biomet Holdings Inc
|
102.69 | 20.44B | 7.60B | 1.08B | 1.26B | 5.26 |
![]()
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
![]()
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
![]()
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
2024-05-30 | Eingeleitet | Goldman | Neutral |
2024-05-21 | Hochstufung | Argus | Hold → Buy |
2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
2023-03-29 | Eingeleitet | UBS | Sell |
2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
2022-10-18 | Eingeleitet | Barclays | Underweight |
2022-10-12 | Eingeleitet | Jefferies | Underperform |
2022-05-27 | Herabstufung | Needham | Buy → Hold |
2022-04-13 | Herabstufung | Truist | Buy → Hold |
2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
2022-02-08 | Bestätigt | Citigroup | Buy |
2022-02-08 | Bestätigt | Deutsche Bank | Hold |
2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
2022-02-08 | Bestätigt | JP Morgan | Neutral |
2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
2022-02-08 | Bestätigt | Stifel | Buy |
2022-02-08 | Bestätigt | Truist | Buy |
2022-02-08 | Bestätigt | UBS | Neutral |
2022-02-08 | Bestätigt | Wells Fargo | Underweight |
2022-02-02 | Herabstufung | UBS | Buy → Neutral |
2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
2021-12-07 | Eingeleitet | Loop Capital | Buy |
2021-11-23 | Herabstufung | Argus | Buy → Hold |
2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
2021-05-25 | Eingeleitet | Barclays | Overweight |
2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
2020-12-18 | Bestätigt | Needham | Strong Buy |
2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
2020-08-05 | Bestätigt | Needham | Strong Buy |
2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
2020-04-07 | Bestätigt | Needham | Strong Buy |
2020-03-05 | Eingeleitet | Citigroup | Buy |
2020-02-13 | Eingeleitet | Goldman | Buy |
2020-01-08 | Eingeleitet | SunTrust | Buy |
2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
2019-08-12 | Hochstufung | Argus | Hold → Buy |
2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Zimmer Biomet Holdings: Hold Rating Amid Competitive Concerns and Growth Projections - TipRanks
Wells Fargo Cuts Zimmer Biomet Price Target to $113 From $117 -February 06, 2025 at 03:04 pm EST - Marketscreener.com
Zimmer Biomet projects 3%-5% revenue growth for 2025 with over 50 product launches in 36 months - MSN
Why Is Zimmer Biomet Stock Trading Lower On Thursday? - Benzinga
Evercore ISI Adjusts Zimmer Biomet Price Target to $110 From $113, Maintains In Line Rating - Marketscreener.com
ZBH's Q4 Earnings Beat, Margins Contract, Stock Down in Premarket - Yahoo Finance
Zimmer Biomet beats The Street in Q4 - Mass Device
Earnings call transcript: Zimmer Biomet Q4 2024 sees strong sales growth - Investing.com
Investors Appear Satisfied With Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Prospects - Simply Wall St
Zimmer Biomet stock slips as outlook disappoints (ZBH:NYSE) - Seeking Alpha
Zimmer Biomet's Dollar Dilemma Dampens 2025 Profit Outlook - Finimize
Zimmer Biomet forecasts 2025 profit below estimates - Yahoo Finance
Zimmer Biomet (NYSE:ZBH) Posts Q4 Sales In Line With Estimates By Stock Story - Investing.com Canada
Zimmer Biomet Q4 Adjusted Earnings, Net Sales Rise; Issues 2025 Guidance -February 06, 2025 at 07:35 am EST - Marketscreener.com
Zimmer Biomet Holdings Inc. Surpasses Q4 Estimates with $2.31 EPS and $2.023 Billion Revenue - GuruFocus.com
Zimmer Biomet earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Zimmer Biomet reports Q4 earnings beat, revenue up 4.3% By Investing.com - Investing.com Australia
Zimmer Biomet reports Q4 earnings beat, revenue up 4.3% - Investing.com
Zimmer: Q4 Earnings Snapshot -February 06, 2025 at 06:45 am EST - Marketscreener.com
Earnings Flash (ZBH) Zimmer Biomet Holdings Posts Q4 Adjusted EPS $2.31, vs. FactSet Est of $1.73 - Marketscreener.com
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results - PR Newswire
Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect - Barchart
Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect By Stock Story - Investing.com Canada
Global Electrosurgery Generators Market on a Growth Trajectory, Expected to Reach USD 3,359.2 Million by 2035 | Future Market Insights, Inc. - GlobeNewswire Inc.
Zimmer Biomet to buy surgical device company Paragon 28 for $1.1B - MSN
Kempner Capital Management Inc. Buys 13,349 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
New Wave Wealth Advisors LLC Takes $257,000 Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Set to Report Q4 Earnings: What's in Store? - MSN
Sivik Global Healthcare LLC Sells 20,000 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
KBC Group NV Has $3.09 Million Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet to buy Paragon 28 for $1.1 billion - MSN
Robeco Institutional Asset Management B.V. Reduces Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Inlet Private Wealth LLC Invests $2.66 Million in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Position Lessened by Costello Asset Management INC - MarketBeat
Everett Harris & Co. CA Reduces Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Bought by Deroy & Devereaux Private Investment Counsel Inc. - MarketBeat
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies business - MSN
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Receives $124.11 Average Price Target from Brokerages - MarketBeat
Gries Financial LLC Invests $866,000 in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet (NYSE:ZBH) Earns Hold Rating from Needham & Company LLC - MarketBeat
Matrix Asset Advisors Inc. NY Has $9.53 Million Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc. -January 31, 2025 at 04:26 pm EST - Marketscreener.com
Zimmer Biomet Stock Price | ZBH Stock Quote, News, and History - Markets Insider
Latham & Watkins Advises on Zimmer Biomet’s Acquisition of Paragon 28 - Legal Desire News Network
Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn - MSN
BTIG maintains Zimmer Biomet stock with $126 target - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid expansion and ERP challenges - MSN
Zimmer Biomet to acquire Paragon 28 - Today's Medical Developments
Paragon 28 stock rating cut to Equal Weight by Stephens - MSN
Zimmer Biomet buying Paragon 28 for $1.1B to bolster F&A offerings - BioWorld Online
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):